8 – 9:50 AM   Cutting Edge Science for Clinicians---Where Is Addiction Treatment Going?

10 – 10:50 AM       Predictors of Substance Use and Misuse in LGBTQ Populations

12 – 1:50 PM        Optimizing Treatment of Substance Users With Psychiatric Comorbidity       

2 – 3:50 PM          Sex and Gender Considerations in Laboratory and Treatment  Outcome Studies in Addiction

4 – 4:50 PM          Poster Session

8 – 9:50 AM      Cognitive Remediation As a Mechanism to Enhance Substance Abuse Treatment

10 – 10:50 AM      Adolescent and Young Adult Substance Abuse---Minority Issues

2 – 2:50 PM          Developmentally Focused Alcohol and Drug Trajectories---What Can They Teach Us?

3 – 3:50 PM          Div 50 Presidential Address

4 – 4:50 PM          Div 50 Business Meeting

5 – 7:50 PM          NIDA- and NIAAA-Sponsored Early Career Poster Session and Social Hour

8 – 9:50 AM           Changing the Trajectories of Genetic Predispositions to Substance Abuse

12-12:50 PM         Co-Occurring Substance Abuse and Mental Disorders—Characteristics at Treatment Initiation: Treatment Implications

2- 2:50 PM             Evidence-Based Practice in Addictions---Valuing RCTs and Therapeutic Relationships

3 – 3:50 PM          Taking Innovative Evidence-Based Alcohol and Drug Treatment Forward

8 – 8:50 AM             Beyond Me---Reducing Disparities in Drug Abuse Through Structural Interventions

9 – 10:50 AM           Linking Practice With Evidence-Based Interventions in Behavioral Health---New Developments

Friday, 11-11:50 Nora Volkow, MD, National Institute on Drug Abuse, Bethesda, MD, "Psychotherapeutic Drug Abuse: It’s Not What the Doctor Ordered”

Friday, 1-1:50    G. Alan Marlatt, PhD, University of Washington, “Moment to Moment: Mindfulness-Based Relapse” Prevention in the Treatment of Addictive Behaviors